Scientists test new Drug's ability to calm artificial lung inflammation
NCT ID NCT06677918
Summary
This early-stage study tested whether an oral drug called EP395 could reduce markers of lung inflammation in healthy adults. Researchers gave 40 participants either EP395 or a placebo for 21 days, then used a safe, inhaled substance to temporarily cause mild airway inflammation to measure the drug's effects. The main goal was to see how EP395 affects specific inflammation markers in blood and phlegm and to check its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Division of Clinical Airway Research
Hanover, 30625, Germany
Conditions
Explore the condition pages connected to this study.